5.3.4 Low HDL cholesterol
As President-elect of the Pacific Lipid Association, it gives me a great pleasure to present our chapter update. Our members continue to be very active in their communities as well as throughout the NLA. Our own Matthew Ito, PharmD, will become the NLA President this May. March of last year, our... more
(1 vote)
A recent succession of negative studies— including two randomized, placebocontrolled intervention trials1, 2 and a large genetic association analysis3—calls for a careful re-examination of the approach to HDL-directed therapies. In May 2011 the Atherothrombosis Intervention in Metabolic... more
No votes yet


.png)







